Doxycycline 200mg Tablets bulk supplier for pharma manufacturers

Doxycycline 200Mg Tablets 200mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 200mg

Reference Brands: Doryx (USA), Doxicip (India), Vibramicina (LATAM)

Doxycycline Tablet is a medicine that is used for the treatment of Bacterial Infections, Sexually Transmitted Diseases, Malaria mainly. Doxycycline Tablet have Doxycycline as an active ingredient. Doxycycline Tablet works by stopping the production bacteria and showing its action

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Doxycycline Tablet is used for the treatment, control, prevention, & improvement of the following diseases and conditions. Bacterial Infections Sexually Transmitted Diseases Malaria

This antibiotic is also effective in treating several sexually transmitted infections (STIs) such as chlamydia, syphilis, and gonorrhea, as well as vector-borne diseases including Lyme disease and certain rickettsial infections. In addition, doxycycline hyclate is frequently used as a preventive treatment for malaria in travelers visiting endemic regions. Recent recommendations from the Centers for Disease Control and Prevention have also highlighted the use of doxycycline as post-exposure prophylaxis (Doxy-PEP) in certain high-risk populations to reduce the risk of bacterial sexually transmitted infections.

Doxycycline 200Mg Tablets — third party manufacturing & bulk supply

Doxycycline 200Mg Tablets 200mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Doxycycline 200Mg Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Doxycycline 200Mg Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Doxycycline 200Mg Tablets →

Back to Listing

Frequently Asked Questions

Doxycycline hyclate is used to treat a wide range of bacterial infections such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, acne, and sexually transmitted infections. It is also used for certain vector-borne diseases including Lyme disease, malaria prevention, and rickettsial infections. It works by inhibiting bacterial protein synthesis, which prevents bacteria from growing and spreading.

Doxycycline hyclate is a semi-synthetic tetracycline antibiotic derived from oxytetracycline. The hyclate salt form improves its solubility and absorption when taken orally.

Doxycycline hyclate is marketed under several trade names worldwide, including Vibramycin, Doryx, Adoxa, Acticlate, Doxy-1, and Doxt-SL depending on the country and manufacturer.

Doxycycline hyclate was originally marketed under the brand Vibramycin by Pfizer. Today, it is manufactured globally by many pharmaceutical companies including Teva Pharmaceutical Industries, Sandoz, and Viatris along with other generic manufacturers.

The generic name of Doxycycline Hyclate is doxycycline hyclate.

Common brand names of doxycycline hyclate include Vibramycin, Doryx, Adoxa, Acticlate, Doxy-1, and Doxt-SL.

Doxycycline hyclate is manufactured in several countries including the United States, India, China, and multiple European countries by different pharmaceutical manufacturers supplying both branded and generic versions.